Oxygen-Guided Therapy for Optimal Rehabilitation for Peripheral Artery Disease

NIH RePORTER · NIH · R41 · $6,937 · view on reporter.nih.gov ↗

Abstract

SUMMARY This Workforce Diversity Supplement proposal seeks to create an opportunity to enhance the resources, environment, and culture of Infrared Rx in our organization's efforts to advance technology to serve patients suffering from disabling peripheral artery disease. At the same time, it reflects our commitment to promoting a diverse workforce and to further career development for underrepresented groups in science and business. In this proposal, we have created a role within the organization for the candidate to expand knowledge, acquire skills, and shape attitudes in science, medicine, and entrepreneurship. Meanwhile, this role will add value to our company, the technology we develop, and the patients we seek to serve.

Key facts

NIH application ID
10545825
Project number
3R41AG074788-01S1
Recipient
INFRARED RX, INC.
Principal Investigator
Kevin K. McCully
Activity code
R41
Funding institute
NIH
Fiscal year
2022
Award amount
$6,937
Award type
3
Project period
2021-09-30 → 2023-08-31